Moderna Inc (MRNA)
108.86
+0.98
(+0.91%)
USD |
NASDAQ |
Apr 24, 16:00
109.00
+0.14
(+0.13%)
After-Hours: 19:38
Moderna Shareholders Equity (Quarterly): 13.85B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.85B |
| September 30, 2023 | 13.46B |
| June 30, 2023 | 16.95B |
| March 31, 2023 | 18.86B |
| December 31, 2022 | 19.12B |
| September 30, 2022 | 17.99B |
| June 30, 2022 | 17.98B |
| March 31, 2022 | 17.08B |
| December 31, 2021 | 14.14B |
| September 30, 2021 | 10.12B |
| June 30, 2021 | 6.704B |
| March 31, 2021 | 3.838B |
| Date | Value |
|---|---|
| December 31, 2020 | 2.561B |
| September 30, 2020 | 2.760B |
| June 30, 2020 | 2.947B |
| March 31, 2020 | 1.641B |
| December 31, 2019 | 1.175B |
| September 30, 2019 | 1.252B |
| June 30, 2019 | 1.339B |
| March 31, 2019 | 1.446B |
| December 31, 2018 | 1.530B |
| September 30, 2018 | 1.076B |
| December 31, 2017 | 625.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.175B
Minimum
Dec 2019
19.12B
Maximum
Dec 2022
9.673B
Average
10.12B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 37.58B |
| Pfizer Inc | 89.01B |
| Eli Lilly and Co | 10.77B |
| Johnson & Johnson | 68.77B |
| Novavax Inc | -716.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.43B |
| Total Liabilities (Quarterly) | 4.572B |
| Current Ratio | 3.424 |